JPWO2020205605A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020205605A5 JPWO2020205605A5 JP2021557938A JP2021557938A JPWO2020205605A5 JP WO2020205605 A5 JPWO2020205605 A5 JP WO2020205605A5 JP 2021557938 A JP2021557938 A JP 2021557938A JP 2021557938 A JP2021557938 A JP 2021557938A JP WO2020205605 A5 JPWO2020205605 A5 JP WO2020205605A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- independently
- dsrna
- rna
- complementary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962826589P | 2019-03-29 | 2019-03-29 | |
| US62/826,589 | 2019-03-29 | ||
| US201962864789P | 2019-06-21 | 2019-06-21 | |
| US62/864,789 | 2019-06-21 | ||
| US201962910842P | 2019-10-04 | 2019-10-04 | |
| US62/910,842 | 2019-10-04 | ||
| PCT/US2020/025432 WO2020205605A2 (en) | 2019-03-29 | 2020-03-27 | OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022528487A JP2022528487A (ja) | 2022-06-13 |
| JPWO2020205605A5 true JPWO2020205605A5 (https=) | 2023-04-03 |
| JP2022528487A5 JP2022528487A5 (https=) | 2023-04-03 |
Family
ID=72667058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557938A Pending JP2022528487A (ja) | 2019-03-29 | 2020-03-27 | Ｃ９ｏｒｆ７２のオリゴヌクレオチドベースの調節 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200385737A1 (https=) |
| EP (1) | EP3946374A4 (https=) |
| JP (1) | JP2022528487A (https=) |
| AU (1) | AU2020252020A1 (https=) |
| CA (1) | CA3133784A1 (https=) |
| WO (1) | WO2020205605A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3277811B1 (en) | 2015-04-03 | 2020-12-23 | University of Massachusetts | Fully stabilized asymmetric sirna |
| US10633653B2 (en) | 2015-08-14 | 2020-04-28 | University Of Massachusetts | Bioactive conjugates for oligonucleotide delivery |
| JP7406793B2 (ja) | 2017-06-23 | 2023-12-28 | ユニバーシティー オブ マサチューセッツ | ２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法 |
| JP7627042B2 (ja) | 2018-08-23 | 2025-02-05 | ユニバーシティー オブ マサチューセッツ | Ｏ－メチルリッチ完全安定化オリゴヌクレオチド |
| CN114072501A (zh) | 2019-05-06 | 2022-02-18 | 马萨诸塞大学 | 抗c9orf72寡核苷酸及相关方法 |
| MX2022001710A (es) | 2019-08-09 | 2022-05-10 | Univ Massachusetts | Oligonucleótidos modificados químicamente dirigidos a los snp. |
| JP2022545118A (ja) * | 2019-08-23 | 2022-10-25 | ユニバーシティー オブ マサチューセッツ | Ｏ－メチルリッチ完全安定化オリゴヌクレオチド |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| WO2021195510A1 (en) * | 2020-03-27 | 2021-09-30 | University Of Massachusetts | Dual-acting sirna based modulation of c9orf72 |
| WO2021242883A1 (en) | 2020-05-26 | 2021-12-02 | University Of Massachusetts | Synthetic oligonucleotides having regions of block and cluster modifications |
| WO2022204430A1 (en) * | 2021-03-24 | 2022-09-29 | Atalanta Therapeutics, Inc. | Double-stranded sirna having patterned chemical modifications |
| EP4313070A4 (en) * | 2021-03-24 | 2025-06-11 | Atalanta Therapeutics, Inc. | Microglial gene silencing using double-stranded siRNA |
| CN117561334A (zh) * | 2021-06-04 | 2024-02-13 | 阿尔尼拉姆医药品有限公司 | 人染色体9开放阅读框72（C9ORF72）iRNA药剂组合物和其使用方法 |
| EP4430191A2 (en) * | 2021-11-08 | 2024-09-18 | University Of Massachusetts | Oligonucleotides for sod1 modulation |
| WO2023133550A2 (en) * | 2022-01-10 | 2023-07-13 | University Of Massachusetts | Oligonucleotides for mecp2 modulation |
| EP4569116A2 (en) * | 2022-08-09 | 2025-06-18 | The University of Massachusetts | Identification of allele-specific target sequences for c9orf72 |
| WO2025085593A1 (en) * | 2023-10-18 | 2025-04-24 | University Of Massachusetts | Oligonucleotides with ethylene glycol modification |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090176725A1 (en) * | 2005-08-17 | 2009-07-09 | Sirna Therapeutics Inc. | Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| US9080171B2 (en) * | 2010-03-24 | 2015-07-14 | RXi Parmaceuticals Corporation | Reduced size self-delivering RNAi compounds |
| HK1212597A1 (zh) * | 2012-10-15 | 2016-06-17 | Isis Pharmaceuticals, Inc. | 用於調節c90rf72表達的組合物 |
| EP4166667A3 (en) * | 2013-10-11 | 2023-08-02 | Ionis Pharmaceuticals, Inc. | Compositions for modulating c9orf72 expression |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| EP3277811B1 (en) * | 2015-04-03 | 2020-12-23 | University of Massachusetts | Fully stabilized asymmetric sirna |
| RS60230B1 (sr) * | 2015-04-16 | 2020-06-30 | Ionis Pharmaceuticals Inc | Kompozicije za moduliranje ekspresije c9orf72 |
| EP4365291A3 (en) * | 2015-06-12 | 2024-08-14 | Alnylam Pharmaceuticals, Inc. | Complement component c5 irna compositions and methods of use thereof |
| BR112018012894A2 (en) * | 2015-12-23 | 2018-12-04 | Crispr Therapeutics Ag | Materials and Methods for Treatment of Amyotrophic Lateral Sclerosis and / or Frontotemporal Lobular Degeneration |
| WO2017132669A1 (en) * | 2016-01-31 | 2017-08-03 | University Of Massachusetts | Branched oligonucleotides |
| EP3576752A4 (en) * | 2017-02-06 | 2020-12-16 | Mpeg La, LLC | MULTIMERIC OLIGONUCLEOTIDES WITH REDUCED RENAL CLEARANCE |
| US11603532B2 (en) * | 2017-06-02 | 2023-03-14 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| JP7406793B2 (ja) * | 2017-06-23 | 2023-12-28 | ユニバーシティー オブ マサチューセッツ | ２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法 |
| WO2019094694A1 (en) * | 2017-11-10 | 2019-05-16 | University Of Massachusetts | Compositions and methods for the treatment of expanded repeat-associated disorders |
| EP4073251A1 (en) * | 2019-12-13 | 2022-10-19 | Alnylam Pharmaceuticals, Inc. | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof |
-
2020
- 2020-03-27 US US16/833,107 patent/US20200385737A1/en active Pending
- 2020-03-27 WO PCT/US2020/025432 patent/WO2020205605A2/en not_active Ceased
- 2020-03-27 EP EP20782396.4A patent/EP3946374A4/en active Pending
- 2020-03-27 CA CA3133784A patent/CA3133784A1/en active Pending
- 2020-03-27 JP JP2021557938A patent/JP2022528487A/ja active Pending
- 2020-03-27 AU AU2020252020A patent/AU2020252020A1/en active Pending
-
2023
- 2023-06-09 US US18/332,415 patent/US20240132892A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10538763B2 (en) | Compounds and methods for modulation of DUX4 | |
| JPWO2020205605A5 (https=) | ||
| JP2021011501A (ja) | キメラ２重鎖核酸 | |
| JP2024056820A (ja) | Ｓｃｎ９ａ発現を調節するためのオリゴヌクレオチド | |
| JP2018516091A5 (https=) | ||
| CN102803284A (zh) | 用于miRNA抑制剂和模拟物的化学修饰基序 | |
| JPWO2020190768A5 (https=) | ||
| CN115397436A (zh) | 用于抑制PNPLA3表达的RNAi剂、其药物组合物和使用方法 | |
| JPWO2021188626A5 (https=) | ||
| JPWO2021216556A5 (https=) | ||
| JPWO2019022196A1 (ja) | 一本鎖オリゴヌクレオチド | |
| US20210315918A1 (en) | Compounds and Methods for Modulation of Transcript Processing | |
| CN119768186A (zh) | 用于向cns组织递送治疗剂的脂质缀合物 | |
| JP2024528252A (ja) | 核酸医薬の徐放性能の強化方法 | |
| JPWO2021119226A5 (https=) | ||
| CN115485381A (zh) | 以apoc3为靶点的反义核酸 | |
| WO2021157730A1 (ja) | 核酸医薬とその使用 | |
| JPWO2021188661A5 (https=) | ||
| JP2025542580A (ja) | 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している短鎖二重鎖ｒｎａ、およびその使用 | |
| CN115698290A (zh) | 用于治疗神经系统疾病的补体组分4抑制剂以及使用它们的相关组合物、系统和方法 | |
| EP4446414A1 (en) | Antisense oligonucleotide complex | |
| WO2024255846A1 (en) | Oligonucleotide formulation | |
| KR20240110595A (ko) | 안정화된 rna 제제 | |
| JPWO2022212231A5 (https=) | ||
| KR20250164214A (ko) | 아탁신-2(ATXN2)의 발현을 억제하기 위한 RNAi 제제, 이의 조성물, 및 사용 방법 |